Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to $145.1 million.

  • Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments fell 79.54% to $145.1 million in Q2 2025 from the same period last year, while for May 2025 it was $145.8 million, marking a year-over-year decrease of 64.48%. This contributed to the annual value of $145.8 million for FY2025, which is 64.48% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments is $145.1 million, which was down 79.54% from $313000.0 recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments' 5-year high stood at $146.2 million during Q2 2024, with a 5-year trough of -$29.5 million in Q4 2024.
  • Moreover, its 5-year median value for Long-Term Debt Repayments was $313000.0 (2025), whereas its average is $35.1 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments surged by 34416000.0% in 2023 and then crashed by 1539740.93% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments (Quarter) stood at $38000.0 in 2021, then grew by 28.95% to $49000.0 in 2022, then skyrocketed by 293.88% to $193000.0 in 2023, then tumbled by 15397.41% to -$29.5 million in 2024, then skyrocketed by 591.33% to $145.1 million in 2025.
  • Its last three reported values are $145.1 million in Q2 2025, $313000.0 for Q1 2025, and -$29.5 million during Q4 2024.